426 related articles for article (PubMed ID: 14677683)
1. Development of improved attenuated and nucleic acid vaccines for heartwater.
Collins NE; Pretorius A; van Kleef M; Brayton KA; Allsopp MT; Zweygarth E; Allsopp BA
Dev Biol (Basel); 2003; 114():121-36. PubMed ID: 14677683
[TBL] [Abstract][Full Text] [Related]
2. An attenuated Ehrlichia ruminantium (Welgevonden stock) vaccine protects small ruminants against virulent heartwater challenge.
Zweygarth E; Josemans AI; Van Strijp MF; Lopez-Rebollar L; Van Kleef M; Allsopp BA
Vaccine; 2005 Feb; 23(14):1695-702. PubMed ID: 15705474
[TBL] [Abstract][Full Text] [Related]
3. Development of improved vaccines for heartwater.
Collins NE; Pretorius A; Van Kleef M; Brayton KA; Zweygarth E; Allsopp BA
Ann N Y Acad Sci; 2003 Jun; 990():474-84. PubMed ID: 12860676
[TBL] [Abstract][Full Text] [Related]
4. Immunisation of sheep against heartwater in The Gambia using inactivated and attenuated Ehrlichia ruminantium vaccines.
Faburay B; Geysen D; Ceesay A; Marcelino I; Alves PM; Taoufik A; Postigo M; Bell-Sakyi L; Jongejan F
Vaccine; 2007 Nov; 25(46):7939-47. PubMed ID: 17920167
[TBL] [Abstract][Full Text] [Related]
5. Experimental use of the attenuated Ehrlichia ruminantium (Welgevonden) vaccine in Merino sheep and Angora goats.
Zweygarth E; Josemans AI; Steyn HC
Vaccine; 2008 Dec; 26 Suppl 6():G34-9. PubMed ID: 19178891
[TBL] [Abstract][Full Text] [Related]
6. Protection against heartwater by DNA immunisation with four Ehrlichia ruminantium open reading frames.
Pretorius A; Collins NE; Steyn HC; van Strijp F; van Kleef M; Allsopp BA
Vaccine; 2007 Mar; 25(12):2316-24. PubMed ID: 17224211
[TBL] [Abstract][Full Text] [Related]
7. Studies of a polymorphic Ehrlichia ruminantium gene for use as a component of a recombinant vaccine against heartwater.
Pretorius A; Liebenberg J; Louw E; Collins NE; Allsopp BA
Vaccine; 2010 Apr; 28(20):3531-9. PubMed ID: 20338214
[TBL] [Abstract][Full Text] [Related]
8. A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge.
Pretorius A; van Kleef M; Collins NE; Tshikudo N; Louw E; Faber FE; van Strijp MF; Allsopp BA
Vaccine; 2008 Aug; 26(34):4363-71. PubMed ID: 18602727
[TBL] [Abstract][Full Text] [Related]
9. Development of improved vaccines for heartwater.
Mahan SM; Barbet AF; Burridge MJ
Dev Biol (Basel); 2003; 114():137-45. PubMed ID: 14677684
[TBL] [Abstract][Full Text] [Related]
10. Vaccination against heartwater using in vitro attenuated Cowdria ruminantium organisms.
Jongejan F; Vogel SW; Gueye A; Uilenberg G
Rev Elev Med Vet Pays Trop; 1993; 46(1-2):223-7. PubMed ID: 8134636
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of five low molecular weight proteins of Ehrlichia ruminantium as potential vaccine components.
Sebatjane SI; Pretorius A; Liebenberg J; Steyn H; Van Kleef M
Vet Immunol Immunopathol; 2010 Oct; 137(3-4):217-25. PubMed ID: 20566221
[TBL] [Abstract][Full Text] [Related]
12. Development of inactivated heartwater (Ehrlichia ruminantium) vaccine in South Africa.
Molepo LC; Byrom B; Weyers B; Abdelatif N; Mahan SM; Burridge MJ; Barbet AF; Latif AA
Ticks Tick Borne Dis; 2022 May; 13(3):101942. PubMed ID: 35339917
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of inactivated vaccines against heartwater in Burkina Faso: impact of Ehrlichia ruminantium genetic diversity.
Adakal H; Stachurski F; Konkobo M; Zoungrana S; Meyer DF; Pinarello V; Aprelon R; Marcelino I; Alves PM; Martinez D; Lefrancois T; Vachiéry N
Vaccine; 2010 Jun; 28(29):4573-80. PubMed ID: 20470791
[TBL] [Abstract][Full Text] [Related]
14. Opportunities in diagnostic and vaccine approaches to mitigate potential heartwater spreading and impact on the American mainland.
Vachiéry N; Marcelino I; Martinez D; Lefrançois T
Dev Biol (Basel); 2013; 135():191-200. PubMed ID: 23689897
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of E. ruminantium genes in DBA/2 mice as potential DNA vaccine candidates for control of heartwater.
Simbi BH; Bowie MV; McGuire TC; Barbet AF; Mahan SM
Ann N Y Acad Sci; 2006 Oct; 1078():424-37. PubMed ID: 17114751
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of the inactivated vaccine dose against heartwater and in vitro quantification of Ehrlichia ruminantium challenge material.
Vachiéry N; Lefrançois T; Esteves I; Molia S; Sheikboudou C; Kandassamy Y; Martinez D
Vaccine; 2006 May; 24(22):4747-56. PubMed ID: 16621174
[TBL] [Abstract][Full Text] [Related]
17. Natural history of Ehrlichia ruminantium.
Allsopp BA
Vet Parasitol; 2010 Feb; 167(2-4):123-35. PubMed ID: 19836892
[TBL] [Abstract][Full Text] [Related]
18. [Field trial of an attenuated vaccine against heartwater disease].
Gueye A; Jongejan F; Mbengue M; Diouf A; Uilenberg G
Rev Elev Med Vet Pays Trop; 1994; 47(4):401-4. PubMed ID: 7770664
[TBL] [Abstract][Full Text] [Related]
19. Sequencing of a 15-kb Ehrlichia ruminantium clone and evaluation of the cpg1 open reading frame for protection against heartwater.
Louw E; Brayton KA; Collins NE; Pretorius A; Van Strijp F; Allsopp BA
Ann N Y Acad Sci; 2002 Oct; 969():147-50. PubMed ID: 12381580
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of an attenuated heartwater (Ehrlichia ruminantium) vaccine administered by the intramuscular route in cattle, sheep and Angora goats.
Latif AA; Steyn HC; Josemans AI; Marumo RD; Pretorius A; Christo Troskie P; Combrink MP; Molepo LC; Haw A; Mbizeni S; Zweygarth E; Mans BJ
Vaccine; 2020 Nov; 38(49):7780-7788. PubMed ID: 33109388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
